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Abstract
Background: Infection with intestinal helminths is common and may contribute to the decreased efficacy of Vibrio cholerae
vaccines in endemic compared to non-endemic areas. However, the immunomodulatory effects of concomitant intestinal
parasitic infection in cholera patients have not been systematically evaluated.
Methods: We evaluated V. cholerae-specific immune responses in a cohort of patients with severe cholera. 361 patients
completed 21 days of observation and 53 (15%) had evidence of a concomitant intestinal parasitic infection based on direct
microscopy. Although there were no significant differences in the vibriocidal or lipopolysaccharide (LPS)-specific immune
responses to V. cholerae, helminth-infected cholera patients had decreased fecal and serum IgA immune responses to the B
subunit of cholera toxin (CTB) as well as a more modest decrease in serum IgG response to CTB. These findings remained
significant for all classes of helminth infection and when controlling for potential confounding variables such as age and
nutritional status. Although we hypothesized the differential effect on CTB and LPS immune responses was due to T-cell-
dependent immunomodulatory effects of helminth infection, we did not find additional evidence to support a classic Th1 or
Th2 polarization of the immune response to V. cholerae infection related to parasite infection.
Conclusions/Significance: The finding that helminth infection has a profound association with the mucosal humoral
immune response to V. cholerae has implications for the development of protective immunity in cholera-endemic areas and
provides an additional basis for deworming programs in cholera-endemic areas. Additional studies, including further
characterization of the role of T cells in the immune response to human V. cholerae infection and the development of an
animal model of co-infection, may provide additional insight into the mechanisms underlying these findings.
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Introduction
V. cholerae is a major cause of diarrhea globally and is estimated
to cause five million cases of cholera annually, resulting in more
than 100,000 deaths [1]. The vast majority of cases occur in
developing countries. Cholera is endemic in Bangladesh, with an
approximate incidence of 200 cases/100,000 individuals per year,
where the majority of fatal cases occur in young children [2,3].
Intestinal parasitic infections are also common among children in
developing countries, and in rural Bangladesh, it is estimated that
80% of children are infected with the intestinal helminth Ascaris
lumbricoides [4].
Despite the demographic overlap, little has been done to
evaluate the epidemiologic, clinical and immunologic aspects of
co-infection with V. cholerae and intestinal parasites. Hospital-based
surveillance in Kolkata, India demonstrated that among children
ages 2 to 10 presenting with acute diarrheal illness with V. cholerae
infection, 30% had evidence of intestinal parasitic infection on
direct stool examination, although the distribution of specific
parasites was not reported [5]. A 30% prevalence of concomitant
parasitic infection was also reported in V. cholerae infected patients
in Kathmandu [6]. Whether intestinal parasitic co-infection
modifies the clinical manifestations of V. cholerae infection in
human is unknown; mice co-infected with the intestinal stage of
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secreted in response to cholera toxin [7].
Co-infection with intestinal parasites may affect the immune
responses to V. cholerae infection. In general, symptomatic infection
with V. cholerae induces long-lasting protective immunity and the
majority of patients with cholera develop robust humoral and
mucosal immune responses. The best studied of the antibacterial
immune responses to V. cholerae is the serum vibriocidal antibody,
which is a complement-dependent bactericidal antibody directed
primarily against V. cholerae LPS [8]. In Bangladesh, vibriocidal
antibodies increase with age and are associated with protection
from infection with V. cholerae [9–11]. Antitoxin immune responses
are primarily directed to the B subunit of cholera toxin (CTB)
[12], and levels of CTB-specific IgA antibodies are associated with
protection from cholera independently of the vibriocidal antibody
titer [13].
Although the effects of concomitant parasitic infection on the
immune response to natural cholera have not been systematically
evaluated, it is hypothesized that intestinal helminth infection may
contribute to the decreased efficacy of live-attenuated V. cholerae
vaccines in endemic compared to non-endemic areas. The live-
attenuated V. cholerae vaccine strain, CVD103-HgR, was created
by deleting the majority of the gene encoding the cholera toxin A
subunit (CTA) [14]. North American and European adult
volunteers ingesting one dose of the vaccine showed vibriocidal
seroconversion in .90% of recipients, but only 16% of children
from an endemic area of Indonesia demonstrated seroconversion
[15]. CVD103-HgR showed 80% protective efficacy against
diarrheal disease when U.S. volunteers were challenged with El
Tor V. cholerae O1 [16]. However, in a large, randomized, placebo-
controlled, double-blinded field trial in a cholera-endemic area of
Indonesia, CVD103-HgR had a protective efficacy of only 14%
[15]. To address the question of whether concomitant parasitic
infection might explain this discordance, Cooper et. al. random-
ized 233 Ecuadorian children with A. lumbricoides infection to
receive albendazole or placebo followed by CVD 103-HgR.
Among those who completed the study, there was a trend towards
higher vibriocidal seroconversion in albendazole recipients (30%
vs 16%, P=0.06) [17]. In a subset of individuals from this study,
those treated with albendazole had an increased IL-2 response to
stimulation of peripheral blood mononuclear cells by the B subunit
of cholera toxin (CTB), suggesting an improved Th1-type response
in children cleared of helminth infection prior to vaccination [18].
Although these data demonstrate that concomitant parasitic
infection dampens the immune response to CVD103-HgR, it
remains unclear whether helminth infection also affects the
protective immune responses following cholera or other cholera
vaccines. To better understand how preexisting infection with
intestinal parasites affects the response to cholera, we evaluated the
results of a prospective, observational study of immunologic
responses to V. cholerae in patients with acute severe dehydrating
diarrhea.
Methods
Study design and subject enrollment
The hospital of the International Centre for Diarrhoeal Disease
Research, Bangladesh (ICDDR,B) provides care for more than
100,000 patients annually, including over 20,000 cholera patients,
the majority of whom are residents of Dhaka city. Cases presenting
to the hospital with severe acute watery diarrhea were eligible for
inclusion in this study if their stool cultures were subsequently
positive for V. cholerae, if they were older than 6 months, and if they
were without significant co-morbid conditions. All patients had
stool and blood specimens collected on the day after presentation
(termed study day 2), to allow for clinical stabilization and
confirmation of a positive stool culture result. Follow-up blood
samples for immunologic analysis were obtained again on study
days 7 and 21. Informed written consent for participation in this
research was obtained from participants or their guardians. The
human experimentation guidelines of the U.S. Department of
Health and Human Services were followed in the conduct of this
research, which was approved by the Institutional Review Board
of the Massachusetts General Hospital and the Research and
Ethical Review Committees of the ICDDR,B.
Microbiologic studies
All cases of cholera were confirmed by culturing stool for V.
cholerae on taurocholate-tellurite-gelatin agar (TTGA). After
overnight incubation of plates, serological confirmation of
suspected V. cholerae colonies was carried out by slide agglutination
[19,20]. In patients with confirmed cholera, stools were examined
for intestinal parasites using direct microscopy. Two slides were
prepared for each cholera patient. For rice-water stools, a drop of
stool was placed directly under a cover slip, and for more solid
stools, a thin preparation was prepared using approximately one to
two grams of stool resuspended in normal saline. A second slide
was prepared using 1% Lugol’s iodine. Slides were prepared using
a 22 mm cover glass, and the entire film was examined for
parasites using light microscopy.
Measurement of vibriocidal and cholera specific antibody
responses in serum and fecal extracts
Vibriocidal antibody assays were performed with methodology
previously described, using guinea pig complement and the
homologous serotype of V. cholerae O1 or O139 as the target
organism [21]. Serum and fecal antibodies specific to CTB, and
LPS were measured by kinetic ELISAs using methods described
previously [22]. 96-well microtiter plates were coated with either
purified LPS (250 ng/well), or sequentially with GM1 ganglioside
(100 ng/well) followed by recombinant CTB (50 ng/well) (gifts of
A.M. Svennerholm). One-hundred fold dilutions of serum samples
Author Summary
Vibrio cholerae causes cholera, a severe diarrhea that may
lead to fatal dehydration if not treated. Cholera occurs
mostly in impoverished areas where there is poor
sanitation and intestinal parasites are also common.
However, little is known about the relationship between
intestinal parasites and cholera. To learn about how
parasites affect the immune response to Vibrio cholerae,
this article describes 361 patients with cholera, including
53 who had intestinal parasitic infection. We found that
cholera patients with parasitic worms had decreased
antibody response to cholera toxin. The decrease was
greatest in IgA antibodies, which are secreted in the
intestine. However, patients with worm infection did not
have a difference in their immune response to lipopoly-
saccharide, a sugar-based molecule that is important for
immunity. These different effects on the immune response
to cholera toxin and lipopolysaccharide could be explained
by the effect of parasitic infection on CD4+ T cells, a type
of cell that influences the development of the antibody
response to proteins such as cholera toxin but may not
always influence the response to sugar-based molecules.
The finding that worm infection is associated with
decreased immune responses to cholera provides an
additional reason for deworming in cholera-endemic areas.
Cholera Immune Responses and Helminths
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forty-fold diluted serum samples were used for CTB specific IgG
subclass antibody detection and eight-fold dilutions for IgE.
For measuring total IgG and IgA responses, horseradish
peroxidase-conjugated secondary antibodies were applied at a
1:1000 dilution (Jackson Laboratories, Bar Harbor, Maine).
Biotinylated mouse monoclonal anti-human subclass-specific
IgG1 (clone 8c/6-39), IgG2 (clone HP6014), IgG3 (clone HP-
6050), and IgG4 (HP-6025) conjugates (Sigma) and IgE (clone G7-
26) conjugate were added at a 1:2000 dilution in PBS-Tween and
incubated for 1 hour at 37uC. A 1:4000 dilution of streptavidin-
conjugated horseradish peroxidase (Thermo-Scientific) was used as
the detection enzyme for biotinylated monoclonal antibodies.
After incubation and washing, the plates were developed using
0.1% ortho-phenylene diamine (Sigma, St. Louis, Missouri) in
0.1 M sodium citrate buffer with 0.1% hydrogen peroxide, and
optical densities (OD) were read kinetically at 450 nm for
5 minutes at 19-s intervals. Antigen specific-IgA levels in fecal
extracts were expressed as a fraction of total IgA in fecal extracts,
which was determined by ELISA using an IgA standard (1 mg/ml)
derived from human colostrum, as described previously [22].
ELISA results were normalized using a pooled convalescent
standard prepared from patients recently recovered from cholera.
Statistical analysis
Analyses were performed using Stata version 9.0 (Stata
Corporation, Inc., College Station, Texas), and R version 2.7.0
(http://cran.r-project.org/). Demographic, clinical and immuno-
logic characteristics of the parasite-infected cases were compared
with characteristics of the cases without evidence of parasitic
infection using the Students’ t-test or Chi
2 statistic for binary
characteristics. Multivariate analysis of baseline characteristics, the
convalescent vibriocidal responses, and the CTB-specific antibody
responses of cases was performed using multiple linear regression
with all possible interaction terms for each variable, and the
criteria for inclusion/exclusion of variables and interaction terms
in the final model based on goodness of fit as determined by a
decrease in Akaike information criterion. All reported p values are
two-tailed.
Results
Characteristics of the cohort
400 patients with acute watery diarrhea due to V. cholerae O1
and O139 were enrolled between January 2001 and June 2006. Of
the 400 patients enrolled, 361 completed (90%) at least 21 days of
follow-up. Of the 400 enrolled patients, 58 (15%) had a
concomitant parasitic infection detected by stool microscopy. Of
361 patients who completed immunologic follow-up, 53 (15%) of
these patients had a concomitant parasitic infection. Of the 39
patients that were lost to follow up, 5 (15%) also had a
concomitant parasitic infection; thus there did not appear to be
a difference in attrition between parasite infected and non-infected
cholera patients in this study. The type of parasitic infection in the
361 patients who completed follow-up is shown in Table 1.
Helminth infection was observed in 41 (77%) of the 53 parasite-
infected cholera cases, with A. lumbricoides being the most common
parasitic infection detected in the cohort.
Additional demographic and clinical data on the cholera
patients are presented in Table 2. The vast majority of patients
in this study had severe disease. Cholera patients presented to the
clinical center an average of 17 hours after the onset of diarrhea,
and over 90% had severe dehydration on presentation. There was
no difference in severity or duration of illness in parasite-infected
verses non-infected individuals. Similarly, there was no difference
in the distribution of blood group phenotype, gender, or infecting
serogroup of V. cholerae (O1 or O139) in the parasite infected versus
non-infected patients.
The average age of the cholera patients enrolled in this study
was 23 years. There was a significant difference in the mean age of
parasite-infected (18 years) versus non-infected patients (24 years).
An equivalent age difference was seen in the helminth- and
protozoa-infected patients, but this difference only reached
statistical significance for the larger helminth infected group. We
anticipated that parasite-infected children might have more
stunted linear growth, but no appreciable difference in height-
for-age was observed between the two groups.
V. cholerae-specific immunologic responses in parasite
infected versus non-infected cholera patients
The acute and convalescent antibody responses to V. cholerae
antigens of parasite-infected and non-infected patients are
presented in Table 3. No significant differences were observed in
the vibriocidal antibody response or in the LPS-specific antibody
responses to severe V. cholerae infection. Only one (1.8%) parasite
infected patient had less than a four-fold increase in their
vibriocidal antibody, while four (1.3%) non-parasite infected
patients had less than a four-fold increase in their vibriocidal
antibody (P=0.73).
Parasite-infected individuals had several significant differences
in their immune responses to the CTB antigen (Table 3). These
included: 1. a lower level of fecal CTB-specific IgA antibodies on
the day after presentation (a difference of 1.1 log2, P=0.0004). 2. a
lower convalescent serum IgA response to CTB (a difference of 0.8
log2,P ,0.0001), and 3. a modestly lower convalescent serum IgG
response to CTB (a difference of 0.3 log2, P=0.03).
To evaluate whether these differences in the immune responses
to CTB were unique to helminth or protozoal infection, we
performed a sub-analysis, as shown in Table 3. Restricting the
analysis to helminth-infected versus non-infected patients revealed
a larger and more statistically robust difference for all three
significant findings, while there was no discernable difference in
CTB responses in protozoa-infected versus non-infected patients.
Table 1. Distribution of parasitic infections in a cohort of
cholera patients in Dhaka, Bangladesh.
Category Number Percent of Cohort
All patients 361 -
Non-infected 308 85%
Parasite infected 53 15%
Helminths
Any helminth 41 11%
Ascaris 35 10%
Hookworm 7 2%
Trichuris 8 2%
Protozoa
Any protozoa 12 3%
Entamoeba 4 1%
Giardia 10 3%
Cryptosporidium 1 ,1%
Multiple parasites 11 3%
doi:10.1371/journal.pntd.0000403.t001
Cholera Immune Responses and Helminths
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were restricted to helminth infection, we compared acute and
convalescent CTB antibodytiters inpatients with differenthelminth
infections, as shown in Figure 1. Individuals infected with all classes
of intestinal helminths had significantly decreased CTB-specific IgA
responses, with patients infected with multiple helminths having the
most impaired CTB-specific IgA response. Again, we observed a
modestbutsimilardecreaseintheCTB-specificIgGresponse across
classesof geohelminths, although this findingonly reached statistical
significance for the aggregate of all helminth-infected patients.
Table 2. Characteristics of parasite-infected and non-infected cholera patients*.
Entire
Cohort
Parasite-
Infected
No
Parasite
P
Value
Helminth
Infected
No
Helminth
P
Value
Protozoa
Infected
No
Protozoa
P
Value
N=361 N=53 N=308 N=41 N=320 N=12 N=349
Demographic Data
Mean Age 23 (615) 18 (611) 24 (615) 0.009 18 (612) 23 (615) 0.02 18 (68) 23 (615) 0.28
Female 196 (54%) 34 (64%) 162 (53%) 0.12 27 (66%) 170 (53%) 0.12 7 (58%) 190 (54%) 0.78
Clinical Data
Duration of Illness 17 (614) 18 (612) 17 (614) 0.63 18 (610) 17 (614) 0.97 22 (612) 17 (614) 0.22
Severe dehydration 326 (91%) 48 (91%) 278 (91%) 1.0 36 (88%) 291 (91%) 0.52 12 (100%) 315 (90%) 0.25
Height-for-Age (Z)** 21.97 (61.13) 22.00 (61.12) 21.97 (61.14) 0.77 2.06 (61.13) 1.96 (61.13) 0.70 1.90 (61.17) 1.98 (61.13) 0.89
Microbiologic
V. cholerae O139 57 (16%) 8 (15%) 49 (16%) 0.88 6 (15%) 51 (16%) 0.83 2 (17%) 55 (16%) 0.93
Blood Group
O 147 (40%) 22 (41%) 124 (40%) 0.88 16 (39%) 130 (41%) 0.83 6 (50%) 140 (40%) 0.50
A 86 (24%) 11 (21%) 75 (24%) 0.56 10 (24%) 76 (24%) 0.94 1 (8%) 85 (24%) 0.20
B 103 (29%) 14 (26%) 89 (29%) 0.70 10 (24%) 93 (30%) 0.52 4 (33%) 99 (28%) 0.71
AB 25 (7%) 6 (11%) 19 (6%) 0.18 5 (12%) 20 (6%) 0.16 1 (8%) 24 (7%) 0.85
*Mean values are reported with 6SD, and numbers of patients are reported with proportion of patients in each category, corresponding to the denominator (N)
indicated in the column heading.
**Height-for-Age (Z) reported for children and adolescents #18 years.
doi:10.1371/journal.pntd.0000403.t002
Table 3. Acute and convalescent V. cholerae-specific immune responses of parasite infected and non-infected cholera patients.
Immunologic
Variable Day
Entire
Cohort
Parasite
Infected
No
Parasite
P
Value
Helminth
Infected
No
Helminth
P
Value
Protozoa
Infected
No
Protozoa
P
Value
N=361 N=53 N=308 N=41 N=320 N=12 N=349
Serum Response*
Vibriocidal response 2 5.8 (62.5) 6.2 (62.5) 5.8 (62.5) 0.27 6.2 (62.3) 5.8 (62.6) 0.38 6.3 (63.3) 5.8 (62.5) 0.51
21 11.2 (61.9) 11.1 (62.5) 11.2 (61.8) 0.84 11.2 (61.9) 11.2 (61.9) 0.81 10.7 (64.2) 11.2 (61.8) 0.42
CTB IgA 2 4.3 (61.2) 4.0 (61.4) 4.4 (61.2) 0.06 4.1 (61.2) 4.3 (61.2) 0.17 3.9 (61.8) 4.3 (61.2) 0.23
21 6.2 (61.2) 5.6 (61.4) 6.3 (61.1) ,0.0001 5.5 (61.4) 6.3 (61.2) ,0.0001 6.0 (61.4) 6.2 (61.1) 0.29
CTB IgG 2 6.6 (61.0) 6.6 (60.8) 6.6 (61.0) 0.90 6.6 (60.8) 6.6 (61.0) 0.87 6.6 (60.9) 6.5 (61.0) 0.58
21 8.2 (60.8) 7.9 (60.8) 8.2 (60.8) 0.01 7.9 (60.8) 8.2 (60.7) 0.01 8.2 (60.5) 8.2 (60.8) 0.90
LPS IgA 2 4.1 (61.3) 4.2 (61.3) 4.1 (61.3) 0.70 4.3 (61.2) 4.1 (61.3) 0.40 3.8 (61.7) 4.1 (61.3) 0.47
21 6.0 (61.7) 5.9 (61.6) 6.0 (61.7) 0.59 5.9 (61.6) 6.0 (61.7) 0.79 5.7 (61.7) 6.0 (61.7) 0.55
LPS IgG 2 6.2 (60.9) 6.1 (60.9) 6.2 (60.9) 0.36 6.1 (60.9) 6.2 (60.9) 0.49 6.1 (61.1) 6.2 (60.9) 0.54
21 7.6 (60.9) 7.5 (60.9) 7.6 (60.9) 0.22 7.5 (60.9) 7.6 (60.9) 0.44 7.3 (61.0) 7.6 (60.9) 0.29
Fecal IgA Response**
Fecal CTB IgA 2 3.7 (61.4) 2.8 (61.6) 3.9 (61.3) 0.0004 2.6 (61.5) 3.8 (61.3) 0.0004 3.3 (61.7) 3.7 (61.4) 0.41
21 4.1 (61.9) 4.3 (61.9) 4.1 (61.9) 0.50 4.4 (61.9) 4.1 (61.9) 0.45 4.1 (62.0) 4.1 (61.9) 0.96
Fecal LPS IgA 2 1.4 (61.4) 1.3 (61.6) 1.4 (61.4) 0.80 1.4 (61.2) 1.4 (61.2) 0.40 2.2 (62.1) 1.3 (61.3) 0.07
21 2.1 (61.8) 2.2 (61.8) 2.1 (61.8) 0.73 2.5 (61.9) 2.1 (61.7) 0.36 1.6 (61.3) 2.1 (61.8) 0.44
*Serum vibriocidal titers are expressed as log2 inverse antibody titers. CTB and LPS antibody levels are expressed as log2 normalized ELISA units.
**Fecal IgA antibody levels are expressed as log2 normalized ELISA units, adjusted for total fecal IgA.
doi:10.1371/journal.pntd.0000403.t003
Cholera Immune Responses and Helminths
www.plosntds.org 4 March 2009 | Volume 3 | Issue 3 | e403Figure 1. CTB specific IgA and IgG responses are shown in cholera patients across classes of helminth infection (A and B,
respectively). The hatched bars indicate the mean log2 transformed CTB titer on day 2, and the dark bars indicate the titer on day 21 and error bars
indicate the standard error of the mean. An asterisk denotes a statistically significant difference between non-infected and infected individuals. All
classes of helminth infected patients had significantly lower CTB IgA immune responses on day 21 compared to non-helminth infected controls.
doi:10.1371/journal.pntd.0000403.g001
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cholera patients
The vibriocidal antibody and the serum CTB-specific IgA
antibody are the only known independent immunologic predictors
of protection against V. cholerae O1 infection, and are thus
important markers of protective immunity to cholera [13]. To
evaluate whether the associations between helminth infection and
immune responses to V. cholerae might be due to confounding, we
conducted a multivariate regression analysis of these immune
responses including age, gender, and blood group for the V. cholerae
O1 serogroup as shown in Table 4.
Multivariate analysis demonstrated that the relationship be-
tween helminth infection and the CTB-specific IgA response was
highly statistically significant and independent of the other
variables included in the model (regression coefficient 20.86,
P=4.8*10
25). In addition, to examine whether nutritional factors
played a role in mediating the relationship between helminth
infection and the immune responses, separate sub-analyses were
performed on children less than 18 years old (for whom height-for-
age data (N=123) were available) and on patients in whom serum
retinol data (N=128) were available. Even in these sub-analyses,
helminth infection remained a significant predictor of the
convalescent IgA response to CTB (regression coefficient 20.81,
P=0.008, and regression coefficient 20.93, P=0.004 respective-
ly), demonstrating that the association between helminth infection
and the convalescent CTB response was independent of possible
interactions with nutritional status. However, no significant
relationship between helminth infection and vibriocidal antibody
levels (P=0.500) was found.
Immunoglobulin subclasses and cytokine responses in
parasite-infected versus non-infected patients
Although CTB-specific IgG responses were significantly de-
creased in helminth infected individuals, the magnitude of this
difference was less than that observed for CTB-specific IgA. To
evaluate whether the association of helminth infection with the
CTB immune response was specific to certain IgG subclasses, and
to assess whether this association had a Th1 or Th2 polarization,
we evaluated the IgG subclass responses of 34 helminth-infected
cases and non-infected controls matched by age (within 2 years),
gender, and infecting serogroup. These results are presented in
Table 5. Compared to the controls, the helminth-infected patients
had lower CTB-specific IgG responses of all subclasses, although
this only reached statistical significance for IgG1 (a difference of
0.8 log2, P=0.03). Among 12 matched pairs with sufficient sample
to measure CTB-specific IgE specific responses, no difference was
observed between cases and controls.
Discussion
This is the first report of the effect of concomitant intestinal
parasitic infection on the human immune response to severe
infection with V. cholerae. The major observation of this study is
that helminth-infected cholera patients have markedly decreased
mucosal immune responses to the immunodominant V. cholerae
protein antigen, CTB. In contrast, helminth- infected patients
responded as well as non-infected patients to the polysaccharide
antigen LPS, measured by both direct ELISA and by their
vibriocidal antibody response – the complement activating
antibody associated with protective immunity to cholera. This
difference in immune responses to CTB was highly statistically
significant and was observed independently for patients with three
major types of helminth infection including Ascaris, Trichuris, and
hookworm infections. The difference was not observed in intestinal
protozoal infection. Furthermore, this observation was indepen-
dent of potential confounders including age and markers of
nutritional status.
What explains the difference in the response of helminth-
infected patients to CTB but not LPS? One possibility is that this
restricted finding is related to immunomodulatory effects of
helminth infection that are specific to CD4+ T-cell responses to
V. cholerae. In a mouse model of the V. cholerae immune response,
humoral responses to the protein antigen CTB are dependent on
an intact population of CD4+ T-cells, while the LPS humoral
immune response evolves in a T-cell independent mechanism, and
Table 4. Multivariate model of the association of helminth
infection with convalescent immune responses in cholera
patients.
Factors associated with
convalescent vibriocidal
antibody titer.*
Regression
Coefficient
Standard
Error P
(Intercept) 12.02 0.229 ,0.0001
Helminth Infection 20.208 0.308 0.50
Age (years) 20.017 0.007 0.02
Male gender 20.549 0.199 0.01
Blood group O 0.407 0.199 0.04
Factors associated with
convalescent CTB IgA
antibody titer.**
Regression
Coefficient
Standard
Error P
(Intercept) 6.46 0.156 ,0.0001
Helminth Infection 20.856 0.207 ,0.0001
Blood group O 20.168 0.238 0.48
Age (years) 20.016 0.006 0.01
Blood group O: Age (years) 0.020 0.009 0.03
*After selection all interaction terms were excluded from the model.
**After selection gender and all interaction terms other than the interaction
between blood group O and age were excluded from the model.
doi:10.1371/journal.pntd.0000403.t004
Table 5. CTB-specific immunoglobulin subclass responses in
helminth-infected and matched non-infected cholera
patients.
Immunoglobulin Day Cases (N=34) Controls (N=34) P
Total IgG 2 6.6 (60.8) 6.8 (61.0) 0.34
21 7.9 (60.8) 8.4 (60.8) 0.03
IgG1 2 3.9 (61.1) 4.1 (60.9) 0.30
21 7.0 (61.5) 7.8 (61.8) 0.03
IgG2 2 2.9 (61.2) 2.9 (61.6) 0.82
21 6.4 (61.5) 6.7 (61.4) 0.36
IgG3 2 5.6 (61.2) 5.1 (61.2) 0.09
21 7.9 (61.5) 8.2 (61.3) 0.36
IgG4 2 4.6 (61.5) 4.5 (61.5) 0.57
21 7.2 (61.8) 7.5 (62.0) 0.33
Total IgE* 2 2.7 (61.1) 2.7 (60.7) 0.87
21 6.2 (61.3) 6.3 (61.3) 0.84
*Only 12 pairs analyzed for total IgE.
doi:10.1371/journal.pntd.0000403.t005
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mice [23,24]. Similarly, in human V. cholerae, humoral LPS
responses may also occur primarily in a T-cell independent
manner. Thus, the differential effect of helminth infection on the
CTB and LPS immune responses may implicate CD4+ T cells as a
target of helminthic immunomodulation.
Previous immunologic studies, primarily using mouse models of
concomitant enteric helminth and bacterial infection, demonstrate
the importance of T-cell dependent immunomodulation by
helminthinfection.Furthermore,thesestudiessuggestthat helminth
infection may result in a relative increased shift in the Th1/Th2
polarization of the immune response, with concomitant helminth
infection favoring a predominantly Th2-type driven immune
response and a decrease in Th1-type immune response [25,26].
Although we similarly hypothesized that helminth infected cholera
patients may have Th2.Th1 polarized immune responses, with
class switch recombination favoring intact responses of IgE and
IgG4 antibodiesand relativelydiminishedIgG1 andIgG3 responses
[27], only IgG1 was significantly different between helminth
infected and non-infected individuals. Thus, although the differen-
tial effect of helminth infection on the CTB and LPS immune
response suggests a possible CD4+ T-cell dependent mechanism,
our IgG subclass studies suggest that the immunomodulatory effect
of concomitant parasitic infection on the immune response to the
mucosal pathogen V. cholerae does not fall easily into a classic Th1 or
Th2 polarization of the immune response.
Instead, our data suggest that the immunomodulating effect of
helminth infection on the humoral immune response to the
mucosal pathogen V. cholerae results predominantly in an overall
decrease in the mucosal antibody response. This hypothesis is
supported by our observation that non-helminth infected patients
demonstrated a much greater ability to mount a rapid (possibly
anamnestic) fecal CTB-specific IgA response on day 2 after the
onset of illness, and that ultimately these non-helminth infected
patients had almost a 2 fold greater increase in their convalescent
serum CTB IgA antibody.
Our study has some notable limitations. The sensitivity of direct
microscopic examination for stool parasites in the setting of acute
watery diarrhea is not well characterized. Theoretically, the
presence of acute watery diarrhea may decrease the sensitivity of
the stool examination for parasites. In a study by Goodman and
colleagues, no significant association between diarrheal stool and
the sensitivity of detection of helminth infections using a direct
sedimentation technique was observed overall, though diarrheal
stool did result in diminished sensitivity for Trichuris eggs [28].
Although acute cholera may result in some false negative tests for
stool helminths, this type of misclassification is most likely to
introduce a bias that would decrease our ability to detect a
difference between helminth infected and non-infected cholera
patients. Despite this possibility, we still found robust, consistent
differences in the CTB immune response across these groups.
Another limitation of this observational study is that causal
relationships are indeterminate. Although we present hypotheses
to account for the difference in the immune response between
helminth infected and non-infected cholera patients, our observa-
tional data falls outside the expected model where concomitant
helminth infection results primarily in a Th2 shifted response to
bacterial co-infection. However, the finding that helminth
infection has a profound association with decreased mucosal
humoral immune responses to V. cholerae infection carries
implications for the development of protective immunity in
cholera endemic areas and may provide an additional rational
basis for deworming programs in cholera endemic areas.
Additional studies, including further characterization of the role
of T cells in the immune response to human V. cholerae infection,
and the development of an animal model of co-infection with
intestinal helminths and V. cholerae might provide additional insight
into the mechanisms underlying these findings.
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